-
Improving blood sugar control in adults with type 2 diabetes mellitus
-
Used in combination with diet and exercise
-
May be used alone or with other diabetes medications

Mounjaro 2.5mg KwikPen
| MRP | : |
|
| Price | : | ₹12,000.00 |
| You Save | : | ₹1,125.00 (8.57%) |
1 Pre-filled Pen(s)
Mounjaro 2.5mg KwikPen is a prescription injection administered once a week to assist adults with type 2 diabetes in managing their blood sugar levels. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that is part of a newer category of medications known as incretin mimetics. This drug is effective in enhancing blood sugar control when diet and exercise alone are insufficient.
The Mounjaro KwikPen is a prefilled, multi-dose pen intended for single-patient use, designed for easy administration at home. Each pen dispenses 0.6 mL of solution per dose and includes a total of 4 fixed doses, with one dose to be administered weekly. Therefore, each pen is intended to last for a month. This user-friendly dosing regimen aids in maintaining consistent blood levels and streamlines the treatment process.
This medication is specifically approved for type 2 diabetes and is not suitable for individuals with type 1 diabetes or diabetic ketoacidosis. Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should refrain from using this treatment. It is essential to use Mounjaro under the guidance of a qualified healthcare professional.